Primary Progressive Multiple Sclerosis

Name: Primary Progressive Multiple Sclerosis
Brand: Springer Verlag
SKU: 9788847022362
Price: 19201 HUF
Availability: InStock

Szerző: G. Comi, M. Filippi

Nyelv:

Kötés: Puha kötésű

Kiadó: Springer Verlag

Elérhetőség: Beszállítói készleten

Küldés 5-8 napon belül

19 201 Ft

"Why are there no effective treatments for my condition? Why do researchers exclude patients with pr...

Információk a könyvről

Szerző

G. Comi, M. Filippi

Nyelv

Angol

Kötés

Könyv - Puha kötésű

Kiadva

2012

oldal

128

EAN

9788847022362

ISBN

9788847022362

Enbook ID

06623906

Kiadó

Springer Verlag

Súly

226

Méretek

155 x 235 x 8

Teljes leírás

"Why are there no effective treatments for my condition? Why do researchers exclude patients with primary progressive multiple sclerosis from enrolling in clinical trials? Please let me know if you hear of studies that I might be allowed to enter or treatments that I could try for my condition. " Thus, in recent years, the sad lament of the patient with primary progressive MS (PPMS). This variant, often in the guise of a chronic progressive myelopathy or, less commonly, progressive cerebellar or bulbar dysfunction, usually responds poorly to corticosteroids and rarely seems to benefit to a significant degree from intensive immunosuppressive treatments. In recent years, most randomized clin ical trials have excluded PPMS patients on two counts. Clinical worsening devel ops slowly in PPMS and may not be recognized during the course of a 2-or 3-year trial even in untreated control patients. This factor alone adds to the potential for a type 2 error or, at the very least, inflates the sample size and duration of the trial. In addition, there is mounting evidence that progressive axonal degeneration and neuronal loss (rather than active, recurrent inflammation) may be important components of the pathology in this form of the disease. Although contemporary trials are evaluating whether PPMS patients may benefit from treatment with the ~-interferons and glatiramer acetate, preliminary, uncontrolled clinical experi ence suggests that the results may not be dramatic.

Érdekelheti

Azok a vásárlók, akik ezt a könyvet megvásárolták, a következőket is megvásárolták

Leggyakrabban keresett

Categories

Authors

Publishers

Termékek

Termékek

Leggyakrabban keresett

Categories

Authors

Publishers

Termékek

Termékek

Primary Progressive Multiple Sclerosis

Információk a könyvről

Teljes leírás

Érdekelheti

Azok a vásárlók, akik ezt a könyvet megvásárolták, a következőket is megvásárolták